BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carrascosa JM, Puig L, Romero IB, Salgado-Boquete L, Del Alcázar E, Lencina JJA, Moreno D, de la Cueva P. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2-Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermosifiliogr 2022;113:T583-609. [PMID: 35748004 DOI: 10.1016/j.ad.2022.01.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ruiz-villaverde R, Rodriguez Fernandez-freire L, Font-ugalde P, Galan-gutierrez M. Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 Weeks) in Three Tertiary Hospitals in Andalucia (Spain). JCM 2022;11:5098. [DOI: 10.3390/jcm11175098] [Cited by in F6Publishing: 1] [Reference Citation Analysis]